Lista de obras -

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

artículo científico publicado en 2012

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact

artículo científico publicado en 2011

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

artículo científico publicado en 2017

Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer

scientific article published on 23 August 2019

Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer.

artículo científico publicado en 2010

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

artículo científico publicado en 2015

Can diet combined with treatment scheduling achieve consistency of rectal filling in patients receiving radiotherapy to the prostate?

scientific article published on 06 September 2011

Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment

artículo científico publicado en 2017

Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial

artículo científico publicado en 2014

Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial

artículo científico publicado en 2015

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

artículo científico publicado en 2013

Identification of new genetic risk factors for prostate cancer

artículo científico publicado en 2008

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

artículo científico publicado en 2009

Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer

artículo científico publicado en 2005

Magnitude of observer error using cone beam CT for prostate interfraction motion estimation: effect of reducing scan length or increasing exposure.

artículo científico publicado en 2015

Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy

artículo científico publicado en 2019

Multiple loci on 8q24 associated with prostate cancer susceptibility

artículo científico publicado en 2009

Multiple loci with different cancer specificities within the 8q24 gene desert

artículo científico publicado en 2008

Multiple newly identified loci associated with prostate cancer susceptibility

artículo científico publicado en 2008

Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.

artículo científico publicado en 2017

Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer.

artículo científico publicado en 2016

Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies

article

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

artículo científico publicado en 2011

Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial

scientific article published on 05 December 2019

Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).

artículo científico publicado en 2014

Lista de obras de

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer

Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer.

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Can diet combined with treatment scheduling achieve consistency of rectal filling in patients receiving radiotherapy to the prostate?

Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment

Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial

Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

Identification of new genetic risk factors for prostate cancer

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer

Magnitude of observer error using cone beam CT for prostate interfraction motion estimation: effect of reducing scan length or increasing exposure.

Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy

Multiple loci on 8q24 associated with prostate cancer susceptibility

Multiple loci with different cancer specificities within the 8q24 gene desert

Multiple newly identified loci associated with prostate cancer susceptibility

Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.

Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer.

Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial

Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).